# d·ªãch: 
## üìã **CH·∫®N ƒêO√ÅN ‚Äì Perforated Peptic Ulcer**

### ‚ùì ·ªû b·ªánh nh√¢n nghi ng·ªù th·ªßng lo√©t d·∫° d√†y t√° tr√†ng, n√™n ch·ªâ ƒë·ªãnh c√°c x√©t nghi·ªám sinh h√≥a v√† h√¨nh ·∫£nh n√†o?

> üîπ ·ªû b·ªánh nh√¢n nghi ng·ªù th·ªßng d·∫° d√†y-t√° tr√†ng, **ch√∫ng t√¥i khuy·∫øn c√°o th·ª±c hi·ªán c√°c x√©t nghi·ªám huy·∫øt h·ªçc th∆∞·ªùng quy v√† ph√¢n t√≠ch kh√≠ m√°u ƒë·ªông m·∫°ch**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng r·∫•t th·∫•p ‚Äì 1D**)

> üîπ ·ªû b·ªánh nh√¢n c√≥ b·ª•ng c·∫•p nghi do th·ªßng lo√©t d·∫° d√†y t√° tr√†ng, **ch√∫ng t√¥i khuy·∫øn c√°o th·ª±c hi·ªán ch·∫©n ƒëo√°n h√¨nh ·∫£nh b·∫±ng CT scan**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

> üîπ ·ªû b·ªánh nh√¢n c√≥ b·ª•ng c·∫•p nghi do th·ªßng lo√©t d·∫° d√†y t√° tr√†ng, **ch√∫ng t√¥i khuy·∫øn c√°o ch·ª•p X-quang ng·ª±c/b·ª•ng t∆∞ th·∫ø ƒë·ª©ng nh∆∞ b∆∞·ªõc ƒë√°nh gi√° ban ƒë·∫ßu n·∫øu ch∆∞a c√≥ s·∫µn CT scan**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

---

### ‚ùì ·ªû b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng, gi√° tr·ªã l√¢m s√†ng c·ªßa c√°c thang ƒëi·ªÉm nh∆∞ Boey ho·∫∑c PULP l√† g√¨?

> üî∏ ·ªû b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng, **ch√∫ng t√¥i ƒë·ªÅ xu·∫•t s·ª≠ d·ª•ng c√°c h·ªá th·ªëng thang ƒëi·ªÉm (bao g·ªìm Boey, PULP v√† ASA) ƒë·ªÉ ph√¢n t·∫ßng nguy c∆° v√† d·ª± ƒëo√°n k·∫øt c·ª•c**  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 2C**)

## üö® **H·ªíI S·ª®C ‚Äì Perforated Peptic Ulcer**

### ‚ùì ·ªû b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng, c·∫ßn ƒë√°nh gi√° nh·ªØng th√¥ng s·ªë n√†o khi ti·∫øp nh·∫≠n t·∫°i khoa C·∫•p c·ª©u?

> üîπ **Ch√∫ng t√¥i khuy·∫øn c√°o ƒë√°nh gi√° s·ªõm v√† nh·∫≠n di·ªán nhanh b·ªánh nh√¢n b·ªã th·ªßng lo√©t d·∫° d√†y t√° tr√†ng k√®m nhi·ªÖm tr√πng huy·∫øt ƒë·ªÉ ph√≤ng ng·ª´a suy ƒëa c∆° quan v√† gi·∫£m t·ª≠ vong**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng trung b√¨nh ‚Äì 1B**)

> üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t s·ª≠ d·ª•ng c√°c h·ªá th·ªëng thang ƒëi·ªÉm (SOFA, qSOFA) ƒë·ªÉ ƒë√°nh gi√° m·ª©c ƒë·ªô n·∫∑ng c·ªßa b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng**  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 2C**)

---

### ‚ùì ·ªû b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng, m·ª•c ti√™u h·ªìi s·ª©c ph√π h·ª£p l√† g√¨? (Hb, HA, lactate,...)

> üîπ **·ªû b·ªánh nh√¢n kh√¥ng ·ªïn ƒë·ªãnh, ch√∫ng t√¥i khuy·∫øn c√°o h·ªìi s·ª©c nhanh ch√≥ng nh·∫±m gi·∫£m t·ª≠ vong**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

> üîπ **·ªû b·ªánh nh√¢n kh√¥ng ·ªïn ƒë·ªãnh, ch√∫ng t√¥i khuy·∫øn c√°o h·ªìi ph·ª•c c√°c ch·ªâ s·ªë sinh l√Ω v·ªõi m·ª•c ti√™u: MAP ‚â• 65 mmHg, n∆∞·ªõc ti·ªÉu ‚â• 0.5 ml/kg/h, v√† b√¨nh th∆∞·ªùng h√≥a lactate**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

> üîπ **Ch√∫ng t√¥i khuy·∫øn c√°o s·ª≠ d·ª•ng c√°c ph∆∞∆°ng ph√°p theo d√µi huy·∫øt ƒë·ªông (x√¢m l·∫•n ho·∫∑c kh√¥ng) ƒë·ªÉ t·ªëi ∆∞u h√≥a chi·∫øn l∆∞·ª£c b√π d·ªãch v√† s·ª≠ d·ª•ng thu·ªëc v·∫≠n m·∫°ch ph√π h·ª£p t·ª´ng c√° nh√¢n**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

## ‚õî **ƒêI·ªÄU TR·ªä KH√îNG PH·∫™U THU·∫¨T ‚Äì Th·ªßng lo√©t d·∫° d√†y t√° tr√†ng**

### ‚ùì ·ªû b·ªánh nh√¢n b·ªã th·ªßng lo√©t d·∫° d√†y t√° tr√†ng, ch·ªâ ƒë·ªãnh ƒëi·ªÅu tr·ªã **kh√¥ng ph·∫´u thu·∫≠t** l√† g√¨?

> üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t kh√¥ng s·ª≠ d·ª•ng th∆∞·ªùng quy ph∆∞∆°ng ph√°p ƒëi·ªÅu tr·ªã kh√¥ng ph·∫´u thu·∫≠t.**  
> ƒêi·ªÅu tr·ªã kh√¥ng ph·∫´u thu·∫≠t (Non-operative management ‚Äì NOM) **ch·ªâ n√™n c√¢n nh·∫Øc trong c√°c tr∆∞·ªùng h·ª£p r·∫•t ch·ªçn l·ªçc**, khi c√≥ b·∫±ng ch·ª©ng **·ªï th·ªßng ƒë√£ t·ª± b·ªãt k√≠n**, x√°c ƒë·ªãnh b·∫±ng ch·ª•p c·∫£n quang tan trong n∆∞·ªõc.  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 2C**)

---

### ‚ùì ·ªû b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng, c√≥ vai tr√≤ n√†o cho can thi·ªáp n·ªôi soi kh√¥ng?

> üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t tr√°nh th·ª±c hi·ªán ƒëi·ªÅu tr·ªã n·ªôi soi nh∆∞ k·∫πp clip, d√°n keo fibrin ho·∫∑c ƒë·∫∑t stent ·ªü b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng**  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 2C**)

## üîß **PH·∫™U THU·∫¨T ‚Äì Th·ªßng lo√©t d·∫° d√†y t√° tr√†ng**

### ‚ùì ·ªû b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng, khi n√†o n√™n ch·ªâ ƒë·ªãnh ph·∫´u thu·∫≠t v√† th·ªùi ƒëi·ªÉm ph·∫´u thu·∫≠t ph√π h·ª£p l√† khi n√†o?

> üîπ **·ªû b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng c√≥ kh√≠ t·ª± do trong ·ªï b·ª•ng (pneumoperitoneum), r√≤ thu·ªëc c·∫£n quang ra ngo√†i l√≤ng ·ªëng ti√™u h√≥a, ho·∫∑c c√≥ d·∫•u hi·ªáu vi√™m ph√∫c m·∫°c**,  
> **ch√∫ng t√¥i khuy·∫øn c√°o ch·ªâ ƒë·ªãnh ph·∫´u thu·∫≠t**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

> üîπ **Ch√∫ng t√¥i khuy·∫øn c√°o ph·∫´u thu·∫≠t c√†ng s·ªõm c√†ng t·ªët**, ƒë·∫∑c bi·ªát ·ªü b·ªánh nh√¢n ƒë·∫øn mu·ªôn v√† b·ªánh nh√¢n >70 tu·ªïi  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng trung b√¨nh ‚Äì 1B**)

---

### ‚ùì ·ªû b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng, ph∆∞∆°ng ph√°p ph·∫´u thu·∫≠t n√†o ph√π h·ª£p h∆°n? (M·ªï h·ªü hay n·ªôi soi?)
- [x] #qu√™n  ‚ùì ·ªû b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng, ph∆∞∆°ng ph√°p ph·∫´u thu·∫≠t n√†o ph√π h·ª£p h∆°n? (M·ªï h·ªü hay n·ªôi soi?)
	üî∏ **·ªû b·ªánh nh√¢n ·ªïn ƒë·ªãnh, ch√∫ng t√¥i ƒë·ªÅ xu·∫•t m·ªï n·ªôi soi n·∫øu c√≥ ƒëi·ªÅu ki·ªán v·ªÅ thi·∫øt b·ªã v√† k·ªπ nƒÉng.**  N·∫øu kh√¥ng c√≥, n√™n m·ªï h·ªü.
	üîπ **·ªû b·ªánh nh√¢n kh√¥ng ·ªïn ƒëinh, ch√∫ng t√¥i khuy·∫øn c√°o m·ªï h·ªü.**

---

### ‚ùì C√≥ vai tr√≤ n√†o cho **kh√¢u kh√¥ng d√πng ch·ªâ (sutureless repair)** kh√¥ng?

> ‚ùî **Hi·ªán ch∆∞a c√≥ ƒë·ªß b·∫±ng ch·ª©ng ƒë·ªÉ ƒë∆∞a ra khuy·∫øn c√°o v·ªÅ ph∆∞∆°ng ph√°p kh√¢u kh√¥ng d√πng ch·ªâ.**

---

### ‚ùì ·ªû b·ªánh nh√¢n c√≥ l·ªó th·ªßng nh·ªè (<2 cm), n√™n ch·ªçn k·ªπ thu·∫≠t ph·∫´u thu·∫≠t n√†o?
- [x] #qu√™n ·ªû b·ªánh nh√¢n c√≥ l·ªó th·ªßng nh·ªè (<2 cm), n√™n ch·ªçn k·ªπ thu·∫≠t ph·∫´u thu·∫≠t n√†o
	üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t kh√¢u tr·ª±c ti·∫øp ·ªï th·ªßng (primary repair)**.
	Hi·ªán **ch∆∞a th·ªÉ khuy·∫øn c√°o r√µ r√†ng** vi·ªác c√≥ n√™n d√πng m·∫£nh n·ªëi m·∫°c n·ªëi (omental patch) ƒë·ªÉ gia c·ªë hay kh√¥ng.

---

### ‚ùì ·ªû b·ªánh nh√¢n c√≥ l·ªó th·ªßng l·ªõn (‚â•2 cm), n√™n ch·ªçn k·ªπ thu·∫≠t ph·∫´u thu·∫≠t n√†o?
- [x] #qu√™n ·ªû b·ªánh nh√¢n c√≥ l·ªó th·ªßng l·ªõn (‚â•2 cm), n√™n ch·ªçn k·ªπ thu·∫≠t ph·∫´u thu·∫≠t n√†o?
	üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t l·ª±a ch·ªçn ph∆∞∆°ng ph√°p m·ªï d·ª±a theo v·ªã tr√≠ lo√©t.**
	- V·ªõi **lo√©t d·∫° d√†y l·ªõn**, n·∫øu nghi ng·ªù √°c t√≠nh ‚Üí n√™n **c·∫Øt ƒëo·∫°n d·∫° d√†y**, k·∫øt h·ª£p **sinh thi·∫øt l·∫°nh t·ª©c th√¨ (frozen section)** n·∫øu c√≥ th·ªÉ.
	  - V·ªõi **lo√©t t√° tr√†ng l·ªõn**, n√™n xem x√©t **c·∫Øt ƒëo·∫°n, ho·∫∑c kh√¢u +/‚àí lo·∫°i tr·ª´ m√¥n v·ªã (pyloric exclusion)**, ho·∫∑c **d·∫´n l∆∞u ƒë∆∞·ªùng m·∫≠t ra ngo√†i** n·∫øu c·∫ßn.
	**Ch·ªâ n√™n m·ªü t√° tr√†ng (duodenostomy)** trong t√¨nh hu·ªëng **r·∫•t ƒë·∫∑c bi·ªát, b·∫•t kh·∫£ kh√°ng**.  
    (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng r·∫•t th·∫•p ‚Äì 2D**)

---

### ‚ùì ·ªû b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng c√≥ s·ªëc nhi·ªÖm tr√πng v√† r·ªëi lo·∫°n sinh l√Ω n·∫∑ng, c√≥ vai tr√≤ n√†o cho ph·∫´u thu·∫≠t theo chi·∫øn l∆∞·ª£c ki·ªÉm so√°t t·ªïn th∆∞∆°ng (damage control surgery)?

> üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t √°p d·ª•ng chi·∫øn l∆∞·ª£c "ph·∫´u thu·∫≠t ki·ªÉm so√°t t·ªïn th∆∞∆°ng" ·ªü b·ªánh nh√¢n s·ªëc nhi·ªÖm tr√πng n·∫∑ng, sinh l√Ω r·ªëi lo·∫°n** nh·∫±m nhanh ch√≥ng ki·ªÉm so√°t t√¨nh tr·∫°ng, sau ƒë√≥ chuy·ªÉn ICU s·ªõm.  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng r·∫•t th·∫•p ‚Äì 2D**)

## üíä **ƒêI·ªÄU TR·ªä KH√ÅNG SINH ‚Äì Perforated Peptic Ulcer**

### ‚ùì C√≥ n√™n ch·ªâ ƒë·ªãnh kh√°ng sinh v√† li·ªáu c√≥ c·∫ßn ƒëi·ªÅu tr·ªã kh√°ng n·∫•m kinh nghi·ªám ·ªü b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng?

> üîπ **Ch√∫ng t√¥i khuy·∫øn c√°o s·ª≠ d·ª•ng kh√°ng sinh ph·ªï r·ªông ·ªü b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng.**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

> üîπ **Ch√∫ng t√¥i khuy·∫øn c√°o l·∫•y m·∫´u d·ªãch ·ªï b·ª•ng ƒë·ªÉ l√†m x√©t nghi·ªám vi sinh (vi khu·∫©n v√† n·∫•m)** ·ªü t·∫•t c·∫£ b·ªánh nh√¢n ƒë∆∞·ª£c ph·∫´u thu·∫≠t, ƒë·ªÉ c√≥ th·ªÉ hi·ªáu ch·ªânh kh√°ng sinh v·ªÅ sau.  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

> üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t kh√¥ng s·ª≠ d·ª•ng thu·ªëc kh√°ng n·∫•m nh∆∞ m·ªôt li·ªáu ph√°p kinh nghi·ªám chu·∫©n ·ªü b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng.**  
> Ch·ªâ n√™n d√πng kh√°ng n·∫•m n·∫øu b·ªánh nh√¢n c√≥ **nguy c∆° cao nhi·ªÖm n·∫•m** (v√≠ d·ª•: suy gi·∫£m mi·ªÖn d·ªãch, tu·ªïi cao, b·ªánh l√Ω n·ªÅn, n·∫±m ICU k√©o d√†i, nhi·ªÖm tr√πng ·ªï b·ª•ng kh√¥ng ki·ªÉm so√°t).  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 2C**)

---

### ‚ùì ·ªû b·ªánh nh√¢n th·ªßng lo√©t d·∫° d√†y t√° tr√†ng, ph√°c ƒë·ªì kh√°ng sinh n√†o ph√π h·ª£p v√† k√©o d√†i bao l√¢u?

> üîπ **Ch√∫ng t√¥i khuy·∫øn c√°o kh·ªüi tr·ªã kh√°ng sinh ph·ªï r·ªông c√†ng s·ªõm c√†ng t·ªët**, ch·ªëng l·∫°i c·∫£ vi khu·∫©n Gram √¢m, Gram d∆∞∆°ng v√† k·ªµ kh√≠, **t·ªët nh·∫•t sau khi ƒë√£ l·∫•y m·∫´u d·ªãch ·ªï b·ª•ng.**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

> üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t s·ª≠ d·ª•ng li·ªáu tr√¨nh kh√°ng sinh ng·∫Øn (3‚Äì5 ng√†y)** ho·∫∑c cho ƒë·∫øn khi c√°c ch·ªâ d·∫•u vi√™m tr·ªü l·∫°i b√¨nh th∆∞·ªùng.  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 2C**)

## ü©∏ **CH·∫®N ƒêO√ÅN ‚Äì Ch·∫£y m√°u lo√©t d·∫° d√†y t√° tr√†ng**

### ‚ùì ·ªû b·ªánh nh√¢n nghi ng·ªù ch·∫£y m√°u lo√©t ti√™u h√≥a, n√™n ch·ªâ ƒë·ªãnh x√©t nghi·ªám sinh h√≥a v√† h√¨nh ·∫£nh n√†o?

> üîπ **·ªû b·ªánh nh√¢n nghi ng·ªù ch·∫£y m√°u lo√©t d·∫° d√†y t√° tr√†ng, ch√∫ng t√¥i khuy·∫øn c√°o th·ª±c hi·ªán:**

- ƒê·ªãnh nh√≥m m√°u
    
- ƒê·ªãnh l∆∞·ª£ng hemoglobin, hematocrit, ƒëi·ªán gi·∫£i
    
- ƒê√°nh gi√° ƒë√¥ng m√°u  
    (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng r·∫•t th·∫•p ‚Äì 1D**)
    

> üî∏ **·ªû b·ªánh nh√¢n nghi ng·ªù ch·∫£y m√°u lo√©t, khi ch∆∞a th·ªÉ n·ªôi soi, ch√∫ng t√¥i ƒë·ªÅ xu·∫•t ch·ª•p CT c√≥ c·∫£n quang.**  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng r·∫•t th·∫•p ‚Äì 2D**)

---

### ‚ùì ·ªû b·ªánh nh√¢n nghi ng·ªù ch·∫£y m√°u lo√©t d·∫° d√†y t√° tr√†ng, vai tr√≤ ch·∫©n ƒëo√°n c·ªßa n·ªôi soi l√† g√¨?

> üîπ **Ch√∫ng t√¥i khuy·∫øn c√°o th·ª±c hi·ªán n·ªôi soi c√†ng s·ªõm c√†ng t·ªët ·ªü b·ªánh nh√¢n nghi ng·ªù ch·∫£y m√°u lo√©t d·∫° d√†y t√° tr√†ng, ƒë·∫∑c bi·ªát v·ªõi nh√≥m nguy c∆° cao.**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

---

### ‚ùì ·ªû b·ªánh nh√¢n c√≥ ch·∫£y m√°u do lo√©t, h√¨nh ·∫£nh n·ªôi soi c√≥ gi√∫p ƒë√°nh gi√° nguy c∆° ch·∫£y m√°u t√°i ph√°t v√† ·∫£nh h∆∞·ªüng ƒë·∫øn x·ª≠ tr√≠ l√¢m s√†ng kh√¥ng?

> üîπ **Ch√∫ng t√¥i khuy·∫øn c√°o s·ª≠ d·ª•ng c√°c d·∫•u hi·ªáu xu·∫•t huy·∫øt g·∫ßn ƒë√¢y tr√™n n·ªôi soi (stigmata of recent hemorrhage)** ƒë·ªÉ h∆∞·ªõng d·∫´n x·ª≠ tr√≠, v√¨ c√°c d·∫•u n√†y **d·ª± ƒëo√°n nguy c∆° t√°i ch·∫£y m√°u.**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

## üöë **H·ªíI S·ª®C ‚Äì Ch·∫£y m√°u lo√©t d·∫° d√†y t√° tr√†ng**

### ‚ùì ·ªû b·ªánh nh√¢n ch·∫£y m√°u lo√©t d·∫° d√†y t√° tr√†ng, c·∫ßn ƒë√°nh gi√° nh·ªØng th√¥ng s·ªë n√†o t·∫°i th·ªùi ƒëi·ªÉm nh·∫≠p khoa C·∫•p c·ª©u v√† ti√™u ch√≠ n√†o gi√∫p x√°c ƒë·ªãnh t√¨nh tr·∫°ng kh√¥ng ·ªïn ƒë·ªãnh?

> üîπ **Ch√∫ng t√¥i khuy·∫øn c√°o ƒë√°nh gi√° y khoa v√† ph·∫´u thu·∫≠t s·ªõm v√† c·∫©n th·∫≠n ·ªü b·ªánh nh√¢n ch·∫£y m√°u lo√©t ƒë·ªÉ ngƒÉn ng·ª´a ch·∫£y m√°u t√°i ph√°t v√† gi·∫£m t·ª≠ vong**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng r·∫•t th·∫•p ‚Äì 1D**)

> üîπ **Ch√∫ng t√¥i khuy·∫øn c√°o ƒë√°nh gi√° nhi·ªÅu y·∫øu t·ªë l√¢m s√†ng (tri·ªáu ch·ª©ng, d·∫•u hi·ªáu v√† x√©t nghi·ªám) ƒë·ªÉ x√°c ƒë·ªãnh b·ªánh nh√¢n ·ªïn ƒë·ªãnh hay kh√¥ng t·∫°i th·ªùi ƒëi·ªÉm nh·∫≠p vi·ªán**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

> üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t s·ª≠ d·ª•ng c√°c thang ƒëi·ªÉm Rockall v√† Glasgow-Blatchford ƒë·ªÉ ƒë√°nh gi√° m·ª©c ƒë·ªô n·∫∑ng c·ªßa b·ªánh v√† h∆∞·ªõng d·∫´n x·ª≠ tr√≠**  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 2C**)

---

### ‚ùì ·ªû b·ªánh nh√¢n ch·∫£y m√°u lo√©t d·∫° d√†y t√° tr√†ng, c√°c m·ª•c ti√™u h·ªìi s·ª©c ph√π h·ª£p l√† g√¨? (Hb, HA, nh·ªãp tim, lactate,...)

> üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t c√°c m·ª•c ti√™u h·ªìi s·ª©c t∆∞∆°ng t·ª± chi·∫øn l∆∞·ª£c "damage control resuscitation" nh∆∞ trong b·ªánh nh√¢n ch·∫•n th∆∞∆°ng ch·∫£y m√°u.**  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

> üîπ **Ch√∫ng t√¥i khuy·∫øn c√°o duy tr√¨ n·ªìng ƒë·ªô Hb ‚â• 7 g/dL trong giai ƒëo·∫°n h·ªìi s·ª©c ban ƒë·∫ßu**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng trung b√¨nh ‚Äì 1B**)

---

üìå **T√≥m t·∫Øt m·ª•c ti√™u h·ªìi s·ª©c trong ch·∫£y m√°u lo√©t d·∫° d√†y:**

| üéØ Th√¥ng s·ªë         | üìç M·ª•c ti√™u                           |
| ------------------- | ------------------------------------- |
| Huy·∫øt s·∫Øc t·ªë (Hb)   | ‚â• 7 g/dL                              |
| HA trung b√¨nh (MAP) | ‚â• 65 mmHg                             |
| Lactate             | H∆∞·ªõng ƒë·∫øn b√¨nh th∆∞·ªùng                 |
| ƒê√°nh gi√° n·∫∑ng       | D·ª±a tr√™n Rockall / Glasgow-Blatchford |

## ‚õî **ƒêI·ªÄU TR·ªä KH√îNG PH·∫™U THU·∫¨T ‚Äì Ch·∫£y m√°u lo√©t d·∫° d√†y t√° tr√†ng**

### ‚ùì ·ªû b·ªánh nh√¢n ch·∫£y m√°u lo√©t d·∫° d√†y t√° tr√†ng, ch·ªâ ƒë·ªãnh cho ƒëi·ªÅu tr·ªã kh√¥ng ph·∫´u thu·∫≠t l√† g√¨?

> üîπ **Ch√∫ng t√¥i khuy·∫øn c√°o ƒëi·ªÅu tr·ªã kh√¥ng ph·∫´u thu·∫≠t l√† ph∆∞∆°ng ph√°p l·ª±a ch·ªçn ƒë·∫ßu ti√™n sau n·ªôi soi**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

üìå ƒêi·ªÅu tr·ªã kh√¥ng ph·∫´u thu·∫≠t tu√¢n theo nguy√™n t·∫Øc **ABCDE**:

- **A**: Airway ‚Äì ki·ªÉm so√°t ƒë∆∞·ªùng th·ªü
    
- **B**: Breathing ‚Äì th√¥ng kh√≠, oxy h√≥a
    
- **C**: Circulation ‚Äì h·ªìi s·ª©c d·ªãch v√† ki·ªÉm so√°t ch·∫£y m√°u
    
- **D**: Drugs ‚Äì d√πng thu·ªëc (PPI, prokinetics, v.v.)
    
- **E**: Endoscopy ho·∫∑c Embolization ‚Äì n·ªôi soi ch·∫©n ƒëo√°n & ƒëi·ªÅu tr·ªã ho·∫∑c can thi·ªáp m·∫°ch n·∫øu c·∫ßn
    

---

### ‚ùì ·ªû b·ªánh nh√¢n ch·∫£y m√°u lo√©t, ch·ªâ ƒë·ªãnh cho **can thi·ªáp n·ªôi soi** l√† g√¨?

> üîπ **Ch√∫ng t√¥i khuy·∫øn c√°o n·ªôi soi ƒëi·ªÅu tr·ªã nh·∫±m c·∫ßm m√°u, gi·∫£m t√°i ch·∫£y m√°u, tr√°nh ph·∫´u thu·∫≠t v√† gi·∫£m t·ª≠ vong**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

- [x] #qu√™n üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t ph√¢n t·∫ßng nguy c∆° theo ƒëi·ªÉm Blatchford ƒë·ªÉ h∆∞·ªõng d·∫´n x·ª≠ tr√≠ t√πy nguy c∆°**
	üìä **Chi·∫øn l∆∞·ª£c x·ª≠ tr√≠ theo ƒëi·ªÉm Blatchford:**
	| üß™ Nh√≥m nguy c∆° | üè• Khuy·∫øn ngh·ªã n·ªôi soi          |
	| --------------- | ------------------------------- |
	| R·∫•t th·∫•p        | N·ªôi soi ngo·∫°i tr√∫ (2C)          |
	| Nguy c∆° th·∫•p    | N·ªôi soi n·ªôi tr√∫ s·ªõm ‚â§ 24h (1C)  |
	| Nguy c∆° cao     | N·ªôi soi n·ªôi tr√∫ kh·∫©n ‚â§ 12h (1C) |





> üîπ **V·ªõi lo√©t c√≥ m√°u ph·ª•t (Forrest Ia), m√°u r·ªâ r·∫£ (Ib), ho·∫∑c m·∫°ch m√°u th·∫•y r√µ (IIa), ch√∫ng t√¥i khuy·∫øn c√°o can thi·ªáp n·ªôi soi c·∫ßm m√°u.**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

> üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t s·ª≠ d·ª•ng k·∫øt h·ª£p hai ph∆∞∆°ng ph√°p n·ªôi soi ƒë·ªÉ c·∫ßm m√°u (dual modality)**  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng trung b√¨nh ‚Äì 2B**)

> üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t c√¢n nh·∫Øc s·ª≠ d·ª•ng n·ªôi soi c√≥ d√≤ Doppler h∆∞·ªõng d·∫´n n·∫øu c√≥ chuy√™n m√¥n**  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng r·∫•t th·∫•p ‚Äì 2D**)

## üíä **ƒêI·ªÄU TR·ªä N·ªòI KHOA ‚Äì Ch·∫£y m√°u lo√©t d·∫° d√†y t√° tr√†ng**

### ‚ùì ·ªû b·ªánh nh√¢n ch·∫£y m√°u lo√©t d·∫° d√†y t√° tr√†ng, ph√°c ƒë·ªì thu·ªëc ph√π h·ª£p (erythromycin, PPI, terlipressin,...) l√† g√¨?

> üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t s·ª≠ d·ª•ng erythromycin tr∆∞·ªõc khi n·ªôi soi**  
> (_kh√°ng sinh nh√≥m macrolid c√≥ t√°c d·ª•ng tƒÉng nhu ƒë·ªông d·∫° d√†y, l√†m s·∫°ch d·∫° d√†y tr∆∞·ªõc n·ªôi soi_)  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng trung b√¨nh ‚Äì 2B**)

> üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t kh·ªüi tr·ªã PPI c√†ng s·ªõm c√†ng t·ªët**  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng trung b√¨nh ‚Äì 2B**)

> üî∏ **Sau khi c·∫ßm m√°u th√†nh c√¥ng b·∫±ng n·ªôi soi, ch√∫ng t√¥i ƒë·ªÅ xu·∫•t truy·ªÅn tƒ©nh m·∫°ch PPI li·ªÅu cao li√™n t·ª•c trong 72 gi·ªù ƒë·∫ßu**  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng trung b√¨nh ‚Äì 2B**)

> üîπ **Ch√∫ng t√¥i khuy·∫øn c√°o ti·∫øp t·ª•c PPI trong 6‚Äì8 tu·∫ßn sau n·ªôi soi c·∫ßm m√°u**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng trung b√¨nh ‚Äì 1B**)

> ‚ùå **Kh√¥ng khuy·∫øn c√°o PPI k√©o d√†i sau 8 tu·∫ßn, tr·ª´ khi b·ªánh nh√¢n c√≤n ti·∫øp t·ª•c s·ª≠ d·ª•ng NSAIDs ho·∫∑c c√≥ y·∫øu t·ªë nguy c∆° cao t√°i lo√©t.**

---

üìå **T√≥m t·∫Øt th·ª±c h√†nh n·ªôi khoa:**

| üì¶ Thu·ªëc            | üíä Ch·ªâ ƒë·ªãnh c·ª• th·ªÉ             | ‚è± Th·ªùi ƒëi·ªÉm          |
| ------------------- | ------------------------------ | -------------------- |
| Erythromycin        | L√†m s·∫°ch d·∫° d√†y tr∆∞·ªõc n·ªôi soi  | 30‚Äì90 ph√∫t tr∆∞·ªõc soi |
| PPI kh·ªüi tr·ªã        | ·ª®c ch·∫ø acid s·ªõm                | Ngay khi nh·∫≠p vi·ªán   |
| PPI truy·ªÅn li√™n t·ª•c | Sau n·ªôi soi c·∫ßm m√°u th√†nh c√¥ng | 72 gi·ªù ƒë·∫ßu           |
| PPI u·ªëng            | Duy tr√¨                        | 6‚Äì8 tu·∫ßn             |
|                     |                                |                      |
|                     |                                |                      |
## üîÅ **CH·∫¢Y M√ÅU T√ÅI PH√ÅT ‚Äì Peptic Ulcer Rebleeding**

### ‚ùì ·ªû b·ªánh nh√¢n ch·∫£y m√°u t√°i ph√°t do lo√©t d·∫° d√†y t√° tr√†ng, vai tr√≤ c·ªßa ƒëi·ªÅu tr·ªã kh√¥ng ph·∫´u thu·∫≠t l√† g√¨?

> üîπ **Ch√∫ng t√¥i khuy·∫øn c√°o n·ªôi soi l√† bi·ªán ph√°p ƒëi·ªÅu tr·ªã ƒë·∫ßu tay trong tr∆∞·ªùng h·ª£p ch·∫£y m√°u t√°i ph√°t**  
> (**Khuy·∫øn c√°o m·∫°nh, b·∫±ng ch·ª©ng ch·∫•t l∆∞·ª£ng th·∫•p ‚Äì 1C**)

> üî∏ **Ch√∫ng t√¥i ƒë·ªÅ xu·∫•t can thi·ªáp m·∫°ch ch·ªçn l·ªçc (transcatheter angioembolization ‚Äì TAE) l√† l·ª±a ch·ªçn thay th·∫ø trong tr∆∞·ªùng h·ª£p c√≥ s·∫µn ngu·ªìn l·ª±c k·ªπ thu·∫≠t**  
> (**Khuy·∫øn c√°o y·∫øu, b·∫±ng ch·ª©ng r·∫•t th·∫•p ‚Äì 2D**)

---

#qu√™n üìå **G·ª£i √Ω th·ª±c h√†nh khi t√°i ch·∫£y m√°u:**
		| ü©∏ T√¨nh hu·ªëng                                      | üõ† H∆∞·ªõng x·ª≠ tr√≠                               |
		| -------------------------------------------------- | --------------------------------------------- |
		| T√°i ch·∫£y m√°u r√µ sau n·ªôi soi ƒë·∫ßu ti√™n               | üëâ N·ªôi soi l·∫∑p l·∫°i                            |
		| N·ªôi soi th·∫•t b·∫°i 2 l·∫ßn ho·∫∑c kh√¥ng th·ª±c hi·ªán ƒë∆∞·ª£c   | üëâ C√¢n nh·∫Øc can thi·ªáp m·∫°ch n·∫øu ƒë·ªß ƒëi·ªÅu ki·ªán   |
		| B·ªánh nh√¢n huy·∫øt ƒë·ªông kh√¥ng ·ªïn ƒë·ªãnh, lo√©t l·ªõn >2 cm | üëâ Chuy·ªÉn m·ªï ngay (xem ph·∫ßn Surgery b√™n d∆∞·ªõi) |
# g·ªëc 
### Diagnosis

**In patients with a suspected perforated¬†peptic ulcer, which are the appropriate biochemical and imaging investigations that should be requested?**

> _In patients with suspected gastroduodenal perforation, we recommend routine laboratory studies and arterial blood gas analysis (strong recommendation based on very low-quality evidences, 1D)._

> _In patients with acute abdomen from suspected perforated peptic ulcer, we recommend a CT scan imaging (Strong recommendation based on low-quality evidences, 1C)._

> _In patients with acute abdomen from suspected perforated peptic ulcer, we recommend to perform chest/abdominal X-ray as the initial routine diagnostic assessment in case a CT scan is not promptly available (Strong recommendation based on low-quality evidences, 1C)._

**In patients with perforated peptic ulcer, what is the clinical value of risk scores such as Boey Score and Pulp score?**

> _In patients with perforated peptic ulcer, we suggest to adopt scoring systems (including the Boey, PULP and ASA score) for risk-stratification of patients and to predict outcomes (weak recommendation, based on low-quality evidences, 2C)_

### Resuscitation

**In patients with perforated peptic ulcer, which parameters should be evaluated ad ED referral?**

> _We recommend prompt evaluation and early recognition of the patient with perforated peptic ulcer associated sepsis to prevent further organ failure and to reduce mortality (strong recommendation based on moderate-quality evidences, 1B)._

> _We suggest adopting scoring systems (SOFA, qSOFA) to evaluate and assess the severity of the disease in patients with perforated peptic ulcer (Weak recommendation based on low-quality evidences, 2 C)._

**In patients with perforated peptic ulcer, which are the appropriate targets for resuscitation (hemoglobin level, blood pressure/heart rate, lactates level, others)?**

> _In unstable patients with perforated peptic ulcer, we recommend performing rapid resuscitation to reduce mortality (strong recommendation based on low quality evidences, 1C)._

> _In unstable patients with perforated peptic ulcer, we recommend restoring physiological parameters with a mean arterial pressure ‚â• 65‚ÄâmmHg, a urine output ‚â• 0.5‚Äâml/kg/h, and a lactate normalization) (strong recommendation based on low-quality evidences,1C)._

> _We suggest utlizing different types of hemodynamic monitoring (invasive or not) to optimize fluids/vasopressor therapy and to individualize the resuscitation strategy (strong recommendation based on low quality evidences, 1C)._

### Non-operative management‚Äîendoscopic treatment

**In patients with perforated peptic ulcer, which are the indications for non-operative management?**

> _In patients with perforated peptic ulcer we suggest against a routinely use of non-operative management; non-operative management (NOM) could be considered in extremely selected cases where perforation has sealed as confirmed on water-soluble contrast study (weak recommendation based on low-quality evidences, 2C)._

**In patients with perforated peptic ulcer is there a role for endoscopic treatment?**

> _In patients with perforated peptic ulcer, we suggest to avoid endoscopic treatment such clipping, fibrin glue sealing, or stenting (Weak recommendation based on low-quality evidences, 2C)_

### Surgery

**In patients with perforated peptic ulcer, which are the indications for surgical treatment and what is the appropriate timing for surgery?**

> _In patients with perforated peptic ulcer with significant pneumoperitoneum or extraluminal contrast extravasation or signs of peritonitis, we recommend operative treatment (Strong recommendation based on low-quality evidences, 1C)_

> _We recommend performing surgery as soon as possible, especially in patients with delayed presentation and patients older than 70‚Äâ‚Äâ‚Äâyears old (strong recommendation based on moderate-quality evidences, 1B)_

**In patients with perforated peptic ulcer, which is the most appropriate surgical approach (open vs laparoscopy)?**

> _In stable patients with perforated peptic ulcer, we suggest a laparoscopic approach. An open approach is recommended in the absence of appropriate laparoscopic skills and equipment (weak recommendation based on moderate-quality evidences, 2B)._

> _In unstable patients with perforated peptic ulcer, we recommend open surgery (strong recommendation based on very low-quality of evidences, 1D)_

**Is there a role for sutureless repair in patients with perforated peptic ulcer?**

> _Based on the available literature, no recommendation could be made about the sutureless repair._

**In patients with perforated peptic ulcer and small perforation (< 2‚Äâcm), which surgical procedure should be adopted?**

> _In patients with perforated peptic ulcer smaller than 2‚Äâcm, we suggest performing primary repair. No recommendation can be made whether the use of an omental patch can provide further protection of the repair (weak recommendation based on low-quality evidences, 2C)_

**In patients with perforated peptic ulcer and large perforation (‚â• 2‚Äâcm), which surgical procedure should be adopted?**

> _We suggest a tailored approach based upon the location of the ulcer for the treatment of perforated peptic ulcer larger than 2‚Äâcm. In case of large gastric ulcers that raise the suspicion of malignancy, we suggest resection with contextual operative frozen pathologic examination whenever possible. In case of large duodenal ulcers, we suggest considering the need of resections or repair plus/minus pyloric exclusion/external bile drainage. We recommend duodenostomy only in extreme circumstances (weak recommendations based on very low-quality evidences, 2D)._

**In patients with perforated peptic ulcer, what is the role of damage control surgery?**

> _In patients with septic shock from a perforated peptic ulcer and signs of severe physiological derangement, we suggest a damage control strategy (Weak recommendation based on very low-quality of evidences, 2D)_

### Antimicrobial therapy

**Should antibiotic therapy be prescribed and should anti-fungal therapy be administrated empirically in patients with perforated peptic ulcer?**

> _In patients with perforated peptic ulcer, we recommend the administration broad-spectrum antibiotics (strong recommendation based on low-quality evidences, 1C)_

> _We recommend the collection¬†of samples for microbiological analysis for both bacteria and fungi in all patients undergoing surgery with subsequent antibiotic therapy adjustment (strong recommendation based on low-quality evidences, 1C_

> _We suggest not to administer antifungal agents as standard empiric therapy in patients with perforated peptic ulcer. Antifungal should be administrated in patients at high risk for fungal infection (e.g., immunocompromised, advanced age, comorbidities, prolonged ICU-stay, unresolved intra-abdominal infections) (weak recommendation based on low-quality evidences, 2C)_

**In patients with perforated peptic ulcer, which antimicrobial regimen should be used and what is its correct duration?**

> _In patients with perforated peptic ulcer, we recommend to start as soon as possible an empiric broad-spectrum antibiotic regimen against a mixture of Gram-negative, Gram-positive, and anaerobic bacteria, possibly after peritoneal fluid has been collected (Strong recommendation based on low-quality evidences, 1C)_

> _In patients with perforated peptic ulcer, we suggest a short-course (3‚Äì5‚Äâdays or until inflammatory markers normalize) antibiotic therapy (weak recommendation based on low-quality evidences, 2C)._

## Bleeding peptic ulcer

### Diagnosis

**In patients with suspected bleeding peptic ulcer, which biochemical and imaging investigations should be requested?**

> _In patients with suspected bleeding peptic ulcer, we recommend blood-typing, determinations of hemoglobin, hematocrit and electrolytes, and coagulation assessment (strong recommendation based on very low-quality evidences, 1D)._

> _In patients with suspected bleeding peptic ulcer, when endoscopy is not available, we suggest performing contrast-enhanced CT scan (weak recommendation based on very low-quality evidences, 2D)_

**In patients with suspected bleeding peptic ulcer, what is the diagnostic role of endoscopy?**

> _In patients with suspected bleeding peptic, ulcer, we recommend performing endoscopy as soon as possible, especially in high-risk patients (Strong recommendation based on low-quality evidences, 1C)_

**In patients with bleeding peptic ulcer, are the endoscopic findings useful to determine the risk for rebleeding and how do they affect the clinical management?**

> _We suggest guiding management decisions according to stigmata of recent hemorrhage during endoscopy because they can predict the risk of further bleeding (strong recommendation based on low-quality evidences, 1C)_

### Resuscitation

**In patients with bleeding peptic ulcer, which parameters should be evaluated at ED referral and which criteria should be adopted to define an unstable patient?**

_We recommend a rapid and careful surgical/medical evaluation of bleeding peptic ulcer disease patients to prevent further bleeding and to reduce mortality (strong recommendation based on very low-quality evidences, 1D)_

_We recommend evaluating several elements (symptoms, signs, and laboratory findings) to assess the stability/instability of patients with bleeding peptic ulcer at ED referral (strong recommendation based on low quality evidences, 1C)_

_In patients with bleeding peptic ulcer, we suggest evaluating patients according to Rockall and Glasgow-Blatchford scoring systems to assess the severity of the disease and to guide therapy (weak recommendation based on low-quality evidences, 1C)._

**In patients with bleeding peptic ulcer, which are the appropriate targets for resuscitation (hemoglobin level, blood pressure/heart rate, lactates level, others)?**

_We recommend several resuscitation targets, similar to those of damage control resuscitation in the bleeding trauma patient (weak recommendation based on low-quality evidences, 1C)._

_In patients with bleeding peptic ulcer, we recommend to maintain an Hb level of at least > 7‚Äâg/dl during the resuscitation phase (strong recommendation based on moderate-quality evidences, 1B)._

### Non-operative management‚Äîendoscopic treatment

**In patients with bleeding peptic ulcer, which are the indications for non-operative management?**

_In patients with bleeding peptic ulcer, we recommend non-operative management as the first line of management after endoscopy (strong recommendation based on low-quality evidences, 1C)._

Non-operative management of bleeding peptic ulcer incorporates principles of ABCDE [[99](https://wjes.biomedcentral.com/articles/10.1186/s13017-019-0283-9#ref-CR99 "Martinez-Alcala A, Monkemuller K. Emerging Endoscopic Treatments for Nonvariceal Upper Gastrointestinal Hemorrhage. Gastrointest Endosc Clin N Am. 2018;28:307‚Äì20.")]:

- Airway control
    
- Breathing‚Äîventilation and oxygenation
    
- Circulation‚Äîfluid resuscitation and control of bleeding
    
- Drugs‚Äîpharmacotherapy with PPIs, prokinetics, etc.
    
- Endoscopy (diagnostic and therapeutic) or embolization (therapeutic)
**In patients with bleeding peptic ulcer, which are the indications for endoscopic treatment?**

_In patients with bleeding peptic ulcer, we recommend endoscopic treatment to achieve hemostasis and reduce re-bleeding, the need for surgery, and mortality (strong recommendation based on low-quality evidences, 1C)._

_We suggest stratifying patients based on the Blatchford score and adopting a risk-stratified management (weak recommendation based on very low-quality evidences, 2D):_

- _In the very low-risk group, we suggest outpatient endoscopy (weak recommendation based on low-quality evidences, 2C)_
    
- _In the low-risk group, we recommend early inpatient endoscopy (‚â§ 24‚Äâh of admission) (strong recommendation based on low-quality evidences, 1C)._
    
- _In the high-risk group, we recommend urgent inpatient endoscopy (‚â§ 12‚Äâh of admission) (strong recommendation based on low-quality evidences, 1C)._
    

_In patients with spurting ulcer (Forrest 1a), oozing ulcer (Forrest 1b), and ulcer with non-bleeding visible vessel (Forrest 2a), endoscopic hemostasis is recommended (strong recommendation based on low-quality evidences, 1C)_

_In patients with bleeding peptic ulcer, we suggest dual modality for endoscopic hemostasis (weak recommendation based on moderate-quality evidences, 2B)_

_In patients with bleeding peptic ulcer, we suggest considering Doppler probe‚Äìguided endoscopic hemostasis if expertise is available (weak recommendation based on very low-quality evidences, 2D)._

**In patients with bleeding peptic ulcer, what is the appropriate pharmacological regimen (erythromycin, PPI, terlipressin, others)?**

_In patients with bleeding peptic ulcer, we suggest administering pre-endoscopy erythromycin (weak recommendation based on moderate-quality evidences, 2B)._

_In patients with bleeding peptic ulcer, we suggest starting PPI therapy as soon as possible (weak recommendation based on moderate-quality evidences, 2B),_

_In patients with bleeding peptic ulcer, after successful endoscopic hemostasis,¬†we suggest administration of high-dose PPI as continuous infusion for the first 72‚Äâh (weak recommendation based on moderate-quality evidences, 2B)._

_In patients with bleeding peptic ulcer, we recommend PPI for 6‚Äì8‚Äâweeks following endoscopic treatment. Long-term PPI is not recommended unless the patient has ongoing NSAID use (strong recommendation based on moderate-quality evidences, 1B)_

**In patients with recurrent bleeding from peptic ulcer, what is the role of non-operative management?**

_In patients with recurrent bleeding from peptic ulcer, we recommend endoscopy as a first-line treatment (strong recommendation based on low-quality evidences, 1C)._

_In patients with recurrent bleeding, we suggest transcatheter angioembolization as an alternative option where resources are available (weak recommendation based on very low-quality evidences, 2D)._

### Angiography, embolization

**In patients with bleeding peptic ulcer, which are the indications for angiography?**

_In patients with bleeding peptic ulcer, we suggest considering angiography for diagnostic purposes as a second-line investigation after a negative endoscopy (weak recommendation based on low-quality evidences, 2C)._

_No recommendation can be made regarding the role of provocation angiography._

**In patients with bleeding peptic ulcer, which are the indications for angioembolization?**

_In hemodinamically stable bleeding peptic ulcer patients, where endoscopic hemostasis fails twice or is not possible/feasible, we suggest angiography with angioembolization where technical skills and equipment are available (weak recommendation based on very low-quality evidences, 2D)_

### Surgery

**In patients with bleeding peptic ulcer, which are the indications for surgical treatment and which is the appropriate timing for surgery?**

_In patients with bleeding peptic ulcer, we suggest surgical hemostasis (or angiographic embolization if immediately available and with appropriate skills) after failure of repeated endoscopy. In patients with hypotension and/or hemodynamic instability and/or ulcer larger than 2‚Äâcm at first endoscopy, we suggest surgical intervention without repeated endoscopy (strong recommendation based on very low-quality evidences, 1D)._

**In patients with bleeding peptic ulcer, what is the most appropriate surgical approach (open vs laparoscopy) and what are the most appropriate surgical procedures?**

_In patients with refractory bleeding peptic ulcer, we suggest surgical intervention with open surgery (weak recommendation based on very low-quality evidences, 2D)._

_In patients operated for bleeding peptic ulcer, we suggest intra-operative endoscopy to facilitate the localization of the bleeding site (weak recommendation based on very low-quality evidences, 2D)._

_We suggest choosing the surgical procedure according to the location and extension of the ulcer and the characteristics of the bleeding vessel (weak recommendation based on low-quality evidences, 2C)_

_An immediate or delayed biopsy is recommended (weak recommendation based on low-quality evidences, 2C)_

**In patients with bleeding peptic ulcer, what is the role of damage control surgery?**

_We suggest considering damage control surgery for patients with hemorrhagic shock and signs of severe physiological derangement, in order to quickly resolve the bleeding and allow a prompt ICU admission (weak recommendation based on very low-quality evidences, 2D)._

Indications for damage control surgery in bleeding peptic ulcer are similar to those for perforated peptic ulcer and are reported in the WSES guidelines on Open Abdomen management in non-trauma patients [[67](https://wjes.biomedcentral.com/articles/10.1186/s13017-019-0283-9#ref-CR67 "Coccolini F, Montori G, Ceresoli M, Catena F, Moore EE, Ivatury R, Biffl W, Peitzman A, Coimbra R, Rizoli S, Kluger Y, Abu-Zidan FM, Sartelli M, De Moya M, Velmahos G, Fraga GP, Pereira BM, Leppaniemi A, Boermeester MA, Kirkpatrick AW, Maier R, Bala M, Sakakushev B, Khokha V, Malbrain M, Agnoletti V, Martin-Loeches I, Sugrue M, Di Saverio S, Griffiths E, Soreide K, Mazuski JE, May AK, Montravers P, Melotti RM, Pisano M, Salvetti F, Marchesi G, Valetti TM, Scalea T, Chiara O, Kashuk JL, Ansaloni L. The role of open abdomen in non-trauma patient: WSES Consensus Paper. World J Emerg Surg. 2017;12:39.")].

### Antimicrobial therapy

**In patients with bleeding peptic ulcer, which are the indications for antimicrobial therapy and for**¬†**_Helicobacter pylori_**¬†**testing?**

_In patients with bleeding peptic ulcer, empirical antimicrobial therapy is not recommended (strong recommendation based on low-quality evidences, 1C)_

_We recommend performing Helicobacter pylori testing in all patients with bleeding peptic ulcer (strong recommendation based on low-quality evidences, 1C)._